The first time Johnson & Johnson faced a lawsuit due to its talc-based baby powder causing cancer was way back in 1999. Since ...

Johnson & Johnson (JNJ), with a market cap of $377.3 billion, is a leading healthcare company based in New Brunswick, New ...

The U.S. Food & Drug Administration has approved Johnson & Johnson's device for a type of condition which causes abnormal ...

Johnson & Johnson closed $10.50 short of its 52-week high ($168.85), which the company reached on September 4th. Supported by ...

ONL Therapeutics Inc. is a classic case of a University of Michigan spinout. The Ann Arbor biotechnology startup netted the largest VC deal in the state in Q3, closing an oversubscribed $65 million ...

Billionaire Woody Johnson, owner of the New York Jets and former U.S. Ambassador to the UK under the Trump administration, is ...

It was one year ago this month that Ashley McEvoy announced her surprising resignation as worldwide chair of J&J MedTech. She ...

Results were presented at Transcatheter Cardiovascular Therapeutics, or TCT, 2024 conference from the first completed pivotal trial on patients ...

Guggenheim raised the firm’s price target on Johnson & Johnson to $162 from $156 and keeps a Neutral rating on the shares. The firm ...

Johnson & Johnson Stock Performance Shares of NYSE:JNJ opened at $160.14 on Wednesday. The company has a market cap of $385.41 billion, a P/E ratio of 9.98, a PEG ratio of 2.90 and a beta of 0.52 ...

George E. Johnson an entrepreneur with a high school education who parlayed a $250 investment into a company that grossed $39 ...

Johnson Controls (JCI) reports Q3 results, beats earnings expectations, and initiates guidance for fiscal 2025. Stock up 31% ...